No Barriers. No Delays. Just Breakthroughs.
Velocity is a campaign to raise and deploy $20 million, focused exclusively on expanding, advancing and accelerating the development of treatments and cures for all types of CMT.
Laura M. MacNeill, CEO, CMT Research Foundation
“Velocity is more than a campaign — it’s a turning point. We are accelerating the pace of discovery and drug development for CMT like never before. This is our moment to break through barriers, bring new treatments to patients faster, and build a future where CMT no longer defines lives. The momentum is real — and we’re just getting started.”
“My goal is simple: cure CMT. I’m supporting Velocity because this organization has the leadership and the focus to get us there. This is the right team — and now is the time.”
Four Pillars of Research Funded by Velocity:
Fast-Track Therapeutics
Fund high-potential projects stuck near the finish line, giving them the resources needed to reach clinical success.
Remove Delivery Roadblocks
Crack the code on drug delivery, getting treatments exactly where they’re needed to stop CMT at its source.
Leverage Partnerships
Bring in the best minds from other disease areas to supercharge CMT research.
Grow Regenerative Revenue
Pursue revenue-generating investment strategies that can fuel even more groundbreaking CMT research.
Contact
Anna Combes
VP of Philanthropy
504-669-6984
[email protected]